Myocardin-related transcription factor A, regulated by serum response factor, contributes to diabetic cardiomyopathy in mice

Aims: Diabetic cardiomyopathy is a significant contributor to the global pandemic of heart failure. In the present study we investigated the involvement of myocardin-related transcription factor A (MRTF-A), a transcriptional regulator, in this process. Materials and methods: Diabetic cardiomyopathy was induced in mice by feeding with a high-fat diet (HFD) or streptozotocin (STZ) injection. Key findings: We report that MRTF-A was up-regulated in the hearts of mice with diabetic cardiomyopathy. MRTF-A expression was also up-regulated by treatment with palmitate in cultured cardiomyocytes in vitro. Mechanistically, serum response factor (SRF) bound to the MRTF-A gene promoter and activated MRTF-A transcription in response to pro-diabetic stimuli. Knockdown of SRF abrogated MRTF-A induction in cardiomyocytes treated with palmitate. When cardiomyocytes conditional MRTF-A knockout mice (MRTF-A CKO) and wild type (WT) mice were placed on an HFD to induce diabetic cardiomyopathy, it was found that the CKO mice and the WT mice displayed comparable metabolic parameters including body weight, blood insulin concentration, blood cholesterol concentration, and glucose tolerance. However, both systolic and diastolic cardiac function were exacerbated by MRTF-A deletion in the heart. Significance: These data suggest that MRTF-A up-regulation might serve as an important compensatory mechanism to safeguard the deterioration of cardiac function during diabetic cardiomyopathy.

Automated summary

In this study, the involvement of MRTF-A, a transcriptional regulator, in diabetic cardiomyopathy was investigated. The results showed that MRTF-A was up-regulated in the hearts of mice with diabetic cardiomyopathy. Mechanistically, SRF bound to the MRTF-A gene promoter and activated its transcription in response to pro-diabetic stimuli. Deletion of MRTF-A in cardiomyocytes exacerbated the deterioration of cardiac function in mice with diabetic cardiomyopathy.